TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/8/23 16:33 | 6/16/23 | CLNN | Clene Inc. | Health | Drug | Pharmaceutical Preparations | Ugwumba Chidozie | AR | TH | Resigned | P.d | 6,000 | 0.8000 | 0 | 7,500 | 136 | 13,019 | I | |||||||||||||||
11/14/22 18:37 | 10/17/22 | PHGE | Biomx Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ugwumba Chidozie | AR | H | Exit For | S.m | -27 | 0.3549 | 0 | -75 | -2 | 2,997 | I | ||||||||||||||
11/14/22 18:17 | 9/16/22 | PHGE | Biomx Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ugwumba Chidozie | AR | H | Exit For | S.m | -107 | 0.3868 | 0 | -277 | -8 | 3,072 | I | ||||||||||||||
11/14/22 17:51 | 8/10/22 | PHGE | Biomx Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ugwumba Chidozie | AR | H | Exit For | S.m | -184 | 0.6384 | 0 | -289 | -8 | 3,349 | I | ||||||||||||||
11/3/22 07:58 | 11/2/22 | CLNN | Clene Inc. | Health | Drug | Pharmaceutical Preparations | Ugwumba Chidozie | UT | D | P | 1,000 | 1.01 | 0 | 990 | 22 | 5,519 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |